KeyBank National Association
IMVT icon

KeyBank National Association’s Immunovant IMVT Stock Holding History

KeyBank National Association’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$342K Buy
+13,784
New +$357K ﹤0.01% 997

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

KeyBank National Association's IMVT Position: Q1 2026 in Review

KeyBank National Association opened a new position in Immunovant (IMVT) in Q1 2026: 13,784 shares worth $342K. The stake represents ﹤0.01% of the portfolio and ranks #997 among its holdings.

215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • KeyBank National Association held 13,784 shares of Immunovant worth $342K as of Q1 2026.
  • Immunovant was a new KeyBank National Association position in Q1 2026.
  • Immunovant made up ﹤0.01% of KeyBank National Association's portfolio in Q1 2026, its #997 holding.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on KeyBank National Association's 13F filing for Q1 2026, filed 24 Apr 2026.